Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Ministry of Education, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Nanning, Guangxi, China.
Cancer Biol Ther. 2024 Dec 31;25(1):2382531. doi: 10.1080/15384047.2024.2382531. Epub 2024 Aug 29.
Mouse orthotopic xenograft tumor models are commonly employed in studies investigating the mechanisms underlying the development and progression of tumors and their preclinical treatment. However, the unavailability of mature and visualized orthotopic xenograft models of nasopharyngeal carcinoma limits the development of treatment strategies for this cancer. The aim of this study was to provide a simple and reliable method for building an orthotopic xenograft model of nasopharyngeal carcinoma. Human nasopharyngeal carcinoma (C666-1-luc) cells, stably expressing the firefly luciferase gene, were injected subcutaneously into the right axilla of BALB/C nude mice. Four weeks later, the resulting subcutaneous tumors were cut into small blocks and grafted into the nasopharynx of immunodeficient BALB/C nude mice to induce tumor formation. Tumor growth was monitored by bioluminescence imaging and small animal magnetic resonance imaging (MRI). The expression of histological and immunological antigens associated with orthotopic xenograft nasopharyngeal carcinoma was analyzed by tissue section analysis and immunohistochemistry (IHC). A visualized orthotopic xenograft nasopharyngeal carcinoma model was successfully developed in this study. Luminescence signal detection, micro-MRI, and hematoxylin and eosin staining revealed the successful growth of tumors in the nasopharynx of the nude mice. Moreover, IHC analysis detected cytokeratin (CK), CK5/6, P40, and P63 expression in the orthotopic tumors, consistent with the reported expression of these antigens in human nasopharyngeal tumors. This study established a reproducible, visual, and less lethal orthotopic xenograft model of nasopharyngeal carcinoma, providing a platform for preclinical research.
鼠原位异种移植肿瘤模型常用于研究肿瘤发生和发展及其临床前治疗的机制。然而,缺乏成熟和可视化的鼻咽癌原位异种移植模型限制了该癌症治疗策略的发展。本研究旨在提供一种简单可靠的方法来构建鼻咽癌的原位异种移植模型。人鼻咽癌(C666-1-luc)细胞,稳定表达荧光素酶基因,皮下注射到 BALB/C 裸鼠的右腋窝。4 周后,将所得皮下肿瘤切成小块,移植到免疫缺陷的 BALB/C 裸鼠的鼻咽部,诱导肿瘤形成。通过生物发光成像和小动物磁共振成像(MRI)监测肿瘤生长。通过组织切片分析和免疫组织化学(IHC)分析,分析与鼻咽癌原位异种移植相关的组织学和免疫抗原的表达。本研究成功建立了可视化的鼻咽癌原位异种移植模型。发光信号检测、微 MRI 和苏木精和伊红染色显示肿瘤在裸鼠鼻咽部成功生长。此外,免疫组织化学分析检测到原位肿瘤中细胞角蛋白(CK)、CK5/6、P40 和 P63 的表达,与这些抗原在人鼻咽癌中的报道表达一致。本研究建立了一种可重现、可视化和致死性较低的鼻咽癌原位异种移植模型,为临床前研究提供了一个平台。